Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, TDS

Shoreline Biome to Launch New DNA Isolation Kit at Miami Winter Symposium 2020


FARMINGTON, Conn., Jan. 24, 2020 /PRNewswire-PRWeb/ -- Shoreline Biome, a microbiome research company that develops tools for characterizing microbiome populations down to the strain level, today announced that the company will debut a novel new DNA isolation kit at the Miami Winter Symposium 2020, taking place January 26-29.

The new product, Shoreline Biome's Rapid Prep kit, is a fast and easy-to-use kit designed for the efficient and unbiased isolation of high molecular weight (HMW) single-stranded DNA (ssDNA) in excess of 40KB from Gram-negative and Gram-positive bacterial and fungal cultures. The ssDNA output is ideal for downstream PCR applications targeting specific microbial, fungal, or mammalian genes of interest.

Additionally, the company will present a poster at the Symposium in collaboration with researchers from West Virginia University School of Medicine.

Shoreline Biome's poster presentation, "Sustained Gut Dysbiosis Following Experimental Sepsis in Alzheimer's Disease Transgenic Mice," is scheduled for Monday, January 27, from 1:30?2:30 p.m. The poster presents research conducted by Allison L. Brichacek, Divine C. Nwafor, Dawn Gratalo, Mark D. Driscoll, and Candice M. Brown. The session will be presented by Brichacek, a student in Brown's lab at West Virginia University School of Medicine.

Shoreline Biome will also be an exhibitor at the Symposium.

The Miami Winter Symposium 2020 will be held January 26?29, 2020, at the Hyatt Regency Miami in Miami, Fla. The symposium is dedicated to molecular mechanisms linking the microbiome and human health. It includes an international line-up of renowned speakers; award lectures by the "stars" of microbiome research; focused sessions on hot topics in microbiome research; the latest international research; and networking opportunities with key research teams from around the world. For more information about the Miami Winter Symposium 2020, visit miamiwintersymposium.com.

About Shoreline Biome:
Characterizing the human microbiome and analyzing its role in human health and disease are priority goals for researchers around the world. Shoreline Biome accelerates breakthroughs in microbiome research by developing transformative discovery tools that characterize microbiome populations down to the strain level. With Shoreline Biome products, all it takes is three easy steps: lyse, purify, and amplify. Shoreline Biome's easy-to-use companion analysis software and comprehensive reference database enables straightforward strain-level identification and quantitation of all bacteria in the sample. To learn more, visit shorelinebiome.com.

 

SOURCE Shoreline Biome


These press releases may also interest you

at 02:00
The Food Equity Initiative and Knoq, have created a "no-contact" specialty delivery service to deliver allergy-free foods to families in need during the Coronavirus outbreak. The COVID-19 pandemic is increasing food insecurity by interrupting income,...

9 avr 2020
Joe's Gluten-Free Foods is recalling Joe's Gluten-Free Foods brand Potato & Onion Perogies from the marketplace because they contain milk which is not declared on the label. People with an allergy to milk should not consume the recalled product...

9 avr 2020
Care Access Research, the leader in rapid development and management of high-performing clinical research sites, announced it launched the COVID-19 Clinical Trials Alliance to connect sites, sponsors and CROs to accelerate COVID-19 trials required...

9 avr 2020
There has been a lot of talk about ventilators and N95 masks, but CRIMADI has observed the reality is that healthcare workers are struggling with a much longer list of shortages every day. And feeling helpless in being able to save as many lives as...

9 avr 2020
The International Sleep Products Association (ISPA) today announced that US mattress manufacturing facilities across the country are working hard to produce and deliver mattresses and other critical products to fellow Americans in need. ...

9 avr 2020
Samsung Biologics (207940.KS) and Vir Biotechnology, Inc. today announced a manufacturing agreement under which Samsung Biologics will perform large scale manufacturing services for Vir's SARS-CoV-2 monoclonal antibody (mAb) program. "We are proud...



News published on 24 january 2020 at 10:00 and distributed by: